Stock Scorecard

Stock Summary for Corcept Therapeutics Inc (CORT) - $37.50 as of 1/12/2026 1:37:23 PM EST

Total Score

12 out of 30

Safety Score

35 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CORT

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CORT

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CORT

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CORT

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CORT (35 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 2
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Financial Details for CORT

Company Overview
Ticker CORT
Company Name Corcept Therapeutics Inc
Country N/A
Description Corcept Therapeutics Incorporated is a biopharmaceutical company headquartered in Menlo Park, California, specializing in the development of innovative therapies that modulate cortisol levels to address severe metabolic, psychiatric, and oncological disorders. The company employs a proprietary approach targeting significant unmet medical needs, bolstered by a robust pipeline of product candidates aimed at improving patient outcomes. As Corcept progresses through its clinical programs, it is well-positioned to create substantial value for both patients and shareholders by fulfilling critical treatment gaps in these therapeutic areas.
Sector Name HEALTHCARE
Industry Name BIOTECHNOLOGY
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History
Last Day Price 37.50
Price 4 Years Ago 20.31
Last Day Price Updated 1/12/2026 1:37:23 PM EST
Last Day Volume 1,613,160
Average Daily Volume 2,193,707
52-Week High 117.33
52-Week Low 32.99
Last Price to 52 Week Low 13.67%

Valuation Measures
Trailing PE N/A
Industry PE 59.48
Sector PE 123.98
5-Year Average PE 35.27
Free Cash Flow Ratio 31.51
Industry Free Cash Flow Ratio 12.53
Sector Free Cash Flow Ratio 29.04
Current Ratio Most Recent Quarter 3.14
Total Cash Per Share 1.19
Book Value Per Share Most Recent Quarter 6.01
Price to Book Ratio 5.96
Industry Price to Book Ratio 66.60
Sector Price to Book Ratio 24.69
Price to Sales Ratio Twelve Trailing Months 5.09
Industry Price to Sales Ratio Twelve Trailing Months 31.26
Sector Price to Sales Ratio Twelve Trailing Months 19.33
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 1

Share Statistics
Total Shares Outstanding 105,188,000
Market Capitalization 3,944,550,000
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.31%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY -61.00%
Annual Earnings Growth 31.65%
Reported EPS 12 Trailing Months 0.87
Reported EPS Past Year 0.62
Reported EPS Prior Year 1.24
Net Income Twelve Trailing Months 105,185,000
Net Income Past Year 139,733,000
Net Income Prior Year 106,140,000
Quarterly Revenue Growth YOY 13.70%
5-Year Revenue Growth 17.11%
Operating Margin Twelve Trailing Months 4.92%

Balance Sheet
Total Cash Most Recent Quarter 125,138,000
Total Cash Past Year 127,665,000
Total Cash Prior Year 135,551,000
Net Cash Position Most Recent Quarter 125,138,000
Net Cash Position Past Year 127,665,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 679,589,000
Total Stockholder Equity Prior Year 506,705,000
Total Stockholder Equity Most Recent Quarter 631,902,000

Free Cash Flow
Free Cash Flow Twelve Trailing Months 162,566,000
Free Cash Flow Per Share Twelve Trailing Months 1.55
Free Cash Flow Past Year 195,895,000
Free Cash Flow Prior Year 126,900,000

Options
Put/Call Ratio 2.10
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -12.31
MACD Signal -8.48
20-Day Bollinger Lower Band 41.46
20-Day Bollinger Middle Band 72.65
20-Day Bollinger Upper Band 103.83
Beta 0.23
RSI 22.32
50-Day SMA 71.75
150-Day SMA 44.97
200-Day SMA 39.77

System
Modified 1/12/2026 8:39:11 PM EST